Zhengye Biotechnology Holding Limited Receivables

Zhengye Biotechnology Holding Limited (ZYBT) currently reports a receivables of $18M as of December 2025. That compares with $89M in the prior-year period — down 79.1% year over year. Use the charts on this page to explore Zhengye Biotechnology Holding Limited's receivables history and peer comparisons.

Zhengye Biotechnology Holding Limited's receivables decreased from $89M to $18M — a 79.1% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zhengye Biotechnology Holding Limited reported $18M in receivables as of December 2025. That compares with $89M in the prior-year period — down 79.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zhengye Biotechnology Holding Limited, and consider following ZYBT for alerts when major investors trade the stock.